Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Fouzia Guestini
Katsuhiko Ono
Minoru Miyashita
Takanori Ishida
Noriaki Ohuchi
Saki Nakagawa
Hisashi Hirakawa
Kentaro Tamaki
Yasuyo Ohi
Yoshiaki Rai
Yasuaki Sagara
Hironobu Sasano
Keely May McNamara
机构：
[1] Tohoku University,
[2] Tohoku Kousai Hospital,undefined
[3] Nahanishi Clinic,undefined
[4] Sagara Hospital,undefined
来源：
Breast Cancer Research and Treatment | 2019年 / 173卷
关键词：
Triple-negative breast cancer; Neoadjuvant chemotherapy; Mechanistic markers; Drug resistance; Residual disease; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：275 / 288
页数：13
相关论文
共 50 条
  • [41] BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study
    Kosaka, Y.
    Yamamoto, Y.
    Nishimiya, H.
    Ibusuki-Yamamoto, M.
    Hirota, Y.
    Tanino, H.
    Iwase, H.
    Nakamura, S.
    Akashi-Tanaka, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [42] Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer
    Zenzola, V.
    Cabezas-Quintario, M. A.
    Arguelles, M.
    Perez-Fernandez, E.
    Izarzugaza, Y.
    Correa, A.
    Garcia-Foncillas, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (11): : 1448 - 1454
  • [43] Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Ma, Tao
    Liu, Xin-Yu
    Cai, Shuang-Long
    Zhang, Jin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [44] Change of Ki-67 after long course of neoadjuvant chemotherapy as prognostic factors in patients with stage II, III triple negative breast cancer
    Yang, Yaewon
    Kim, Tae-Yong
    Im, Seock-Ah
    Keam, Bhumsuk
    Lee, Kyung-Hun
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Tae-You
    Moon, Hyeong-Gon
    Han, Wonshik
    Park, In Ae
    Noh, Dong-Young
    CANCER RESEARCH, 2015, 75
  • [45] The Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
    Carroll, Jennifer F.
    Hoskin, Tanya L.
    Ferre, Roberto A. Leon
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S8 - S8
  • [46] Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
    Carroll, Jennifer F.
    Hoskin, Tanya L.
    Leon-Ferre, Roberto A.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5132 - 5140
  • [47] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    BIOSCIENCE REPORTS, 2019, 39
  • [48] Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients
    Cavallone, Luca
    Adriana, Aguilar-Mahecha
    Aldamry, Mohammed
    Lafleur, Josianne
    Cathy, Lan
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Ferrario, Cristiano
    Mihalciou, Catalin
    Roy, Josee-Anne
    Markus, Elisabeth
    Robidoux, Andre
    Pelmus, Manuela
    Aleynikova, Olga
    Discepola, Federico
    Basik, Mark
    CANCER RESEARCH, 2018, 78 (04)
  • [49] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [50] A brief review of treatment options for neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Tiwari, Akash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 247 - 249
12345